{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T21:53:13Z","timestamp":1768341193784,"version":"3.49.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.bulcan.2025.06.001","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T01:50:38Z","timestamp":1751421038000},"page":"867-874","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cancer du sein chez la femme en \u00e2ge de procr\u00e9er\u00a0: probl\u00e9matiques autour du r\u00f4le des hormones"],"prefix":"10.1016","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3988-4232","authenticated-orcid":false,"given":"Ondine","family":"Dufour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9a","family":"Villeneuve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blandine","family":"Courbiere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"de Nonneville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bulcan.2025.06.001_bib0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12968\/hmed.2021.0459","article-title":"Breast cancer: presentation, investigation and management","volume":"83","author":"Katsura","year":"2022","journal-title":"Br J Hosp Med (Lond)"},{"issue":"9","key":"10.1016\/j.bulcan.2025.06.001_bib0265","doi-asserted-by":"crossref","first-page":"659","DOI":"10.5603\/GP.2016.0062","article-title":"Breast cancer in young women","volume":"87","author":"Radecka","year":"2016","journal-title":"Ginekol Pol"},{"issue":"6","key":"10.1016\/j.bulcan.2025.06.001_bib0270","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1200\/OP.20.00793","article-title":"Breast cancer in adolescent and young adult women under the age of 40\u00a0years","volume":"17","author":"Cathcart-Rake","year":"2021","journal-title":"JCO Oncol Pract"},{"issue":"5","key":"10.1016\/j.bulcan.2025.06.001_bib0275","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.canep.2013.05.001","article-title":"Trends in incidence of breast cancer among women under 40\u00a0in seven European countries: a GRELL cooperative study","volume":"37","author":"Lecl\u00e8re","year":"2013","journal-title":"Cancer Epidemiol"},{"issue":"12","key":"10.1016\/j.bulcan.2025.06.001_bib0280","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.ejso.2011.08.133","article-title":"Breast cancer in very young women","volume":"37","author":"Liukkonen","year":"2011","journal-title":"Eur J Surg Oncol"},{"issue":"20","key":"10.1016\/j.bulcan.2025.06.001_bib0285","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1200\/JCO.2007.14.2471","article-title":"Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression","volume":"26","author":"Anders","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2025.06.001_bib0290","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.breast.2023.02.004","article-title":"Early breast cancer in women aged 35\u00a0years or younger: a large national multicenter French population-based case control-matched analysis","volume":"68","author":"Dufour","year":"2023","journal-title":"Breast"},{"key":"10.1016\/j.bulcan.2025.06.001_bib0295","first-page":"241","article-title":"A review of modifiable risk factors in young women for the prevention of breast cancer","volume":"13","author":"Daly","year":"2021","journal-title":"Breast Cancer (Dove Med Press)"},{"issue":"9","key":"10.1016\/j.bulcan.2025.06.001_bib0300","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.3390\/ijerph18094638","article-title":"Use of oral contraceptives as a potential risk factor for breast cancer: a systematic review and meta-analysis of case-control studies up to 2010","volume":"18","author":"Kanadys","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"23","key":"10.1016\/j.bulcan.2025.06.001_bib0305","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1056\/NEJMoa1700732","article-title":"Contemporary hormonal contraception and the risk of breast cancer","volume":"377","author":"M\u00f8rch","year":"2017","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.bulcan.2025.06.001_bib0310","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/ijc.31266","article-title":"Progestin-only and combined oral contraceptives and receptor-defined premenopausal breast cancer risk: the Norwegian Women and Cancer Study","volume":"142","author":"Busund","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bulcan.2025.06.001_bib0315","doi-asserted-by":"crossref","first-page":"100470","DOI":"10.1016\/j.lanepe.2022.100470","article-title":"Hormonal contraception and risk of breast cancer and breast cancer in situ among Swedish women 15-34\u00a0years of age: a nationwide register-based study","volume":"21","author":"Niemeyer Hultstrand","year":"2022","journal-title":"Lancet Reg Health Eur"},{"issue":"3","key":"10.1016\/j.bulcan.2025.06.001_bib0320","doi-asserted-by":"crossref","first-page":"e1004188","DOI":"10.1371\/journal.pmed.1004188","article-title":"Combined and progestagen-only hormonal contraceptives and breast cancer risk: a UK nested case-control study and meta-analysis","volume":"20","author":"Fitzpatrick","year":"2023","journal-title":"PLoS Med"},{"issue":"4","key":"10.1016\/j.bulcan.2025.06.001_bib0325","doi-asserted-by":"crossref","first-page":"450.e1","DOI":"10.1016\/j.ajog.2024.05.011","article-title":"Association of levonorgestrel-releasing intrauterine device with gynecologic and breast cancers: a national cohort study in Sweden","volume":"231","author":"Yi","year":"2024","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.bulcan.2025.06.001_bib0330","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3892\/mco.2017.1259","article-title":"Association between oral contraceptive use as a risk factor and triple-negative breast cancer: a systematic review and meta-analysis","volume":"7","author":"Li","year":"2017","journal-title":"Mol Clin Oncol"},{"issue":"6","key":"10.1016\/j.bulcan.2025.06.001_bib0335","doi-asserted-by":"crossref","first-page":"580.e1","DOI":"10.1016\/j.ajog.2017.02.002","article-title":"Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners\u2019 Oral Contraception Study","volume":"216","author":"Iversen","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.bulcan.2025.06.001_bib0340","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S1470-2045(12)70425-4","article-title":"Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964\u00a0women with breast cancer from 117\u00a0epidemiological studies","volume":"13","year":"2012","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.bulcan.2025.06.001_bib0345","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial","volume":"288","year":"2002","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.bulcan.2025.06.001_bib0350","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/jama.2020.9482","article-title":"Association of menopausal hormone therapy with breast cancer incidence and mortality during long-term follow-up of the women's health initiative randomized clinical trials","volume":"324","author":"Chlebowski","year":"2020","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.bulcan.2025.06.001_bib0355","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/PPO.0000000000000591","article-title":"Menopausal hormone replacement therapy and reduction of all-cause mortality and cardiovascular disease: it's about time and timing","volume":"28","author":"Hodis","year":"2022","journal-title":"Cancer J Sudbury Mass"},{"issue":"10","key":"10.1016\/j.bulcan.2025.06.001_bib0360","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/aje\/kwu347","article-title":"Hormone therapy and young-onset breast cancer","volume":"181","author":"O\u2019Brien","year":"2015","journal-title":"Am J Epidemiol"},{"issue":"5","key":"10.1016\/j.bulcan.2025.06.001_bib0365","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1002\/ijc.29069","article-title":"Risk of breast cancer following fertility treatment--a registry based cohort study of parous women in Norway","volume":"136","author":"Reigstad","year":"2015","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1016\/j.bulcan.2025.06.001_bib0370","doi-asserted-by":"crossref","first-page":"102031","DOI":"10.1016\/j.esmoop.2023.102031","article-title":"Safety of pregnancy after breast cancer in young women with hormone receptor-positive disease: a systematic review and meta-analysis","volume":"8","author":"Arecco","year":"2023","journal-title":"ESMO Open"},{"issue":"1","key":"10.1016\/j.bulcan.2025.06.001_bib0375","doi-asserted-by":"crossref","first-page":"zrab149","DOI":"10.1093\/bjsopen\/zrab149","article-title":"Fertility treatment and breast-cancer incidence: meta-analysis","volume":"6","author":"Cullinane","year":"2022","journal-title":"BJS Open"},{"key":"10.1016\/j.bulcan.2025.06.001_bib0380","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ejca.2022.05.013","article-title":"What should be done in terms of fertility preservation for patients with cancer? The French 2021\u00a0guidelines","volume":"173","author":"Rives","year":"2022","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.bulcan.2025.06.001_bib0385","first-page":"557","article-title":"Restatement. Cancer and fertility preservation","volume":"73","author":"Courbiere","year":"2023","journal-title":"Rev Prat"},{"issue":"4","key":"10.1016\/j.bulcan.2025.06.001_bib0390","doi-asserted-by":"crossref","first-page":"hoaa052","DOI":"10.1093\/hropen\/hoaa052","article-title":"ESHRE guideline: female fertility, preservation","volume":"2020","author":"Anderson","year":"2020","journal-title":"Hum Reprod Open"},{"issue":"8","key":"10.1016\/j.bulcan.2025.06.001_bib0395","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2174\/1389201018666170808122531","article-title":"Random start ovarian stimulation for oocyte or embryo cryopreservation in women desiring fertility preservation prior to gonadotoxic cancer therapy","volume":"18","author":"Danis","year":"2017","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.bulcan.2025.06.001_bib0400","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejca.2022.07.017","article-title":"Efficacy and safety of controlled ovarian hyperstimulation with or without letrozole for fertility preservation in breast cancer patients: a multicenter retrospective study","volume":"174","author":"Goldrat","year":"2022","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.bulcan.2025.06.001_bib0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.102228","article-title":"Is controlled ovarian stimulation safe in patients with hormone receptor-positive breast cancer receiving neoadjuvant chemotherapy?","volume":"9","author":"Benvenuti","year":"2024","journal-title":"ESMO Open"},{"issue":"12S1","key":"10.1016\/j.bulcan.2025.06.001_bib0410","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/S0007-4551(20)30047-3","article-title":"Oncofertility and breast cancer","volume":"106","author":"Sonigo","year":"2019","journal-title":"Bull Cancer (Paris)"},{"key":"10.1016\/j.bulcan.2025.06.001_bib0415","unstructured":"Pr\u00e9servation de la fertilit\u00e9 et cancer \u2013\u00a0Th\u00e9saurus\u00a0\u2013 Ref\u00a0: RRETHESCATFERT21 [Internet] [cit\u00e9 5\u00a0septembre 2024]. Disponible sur\u00a0: https:\/\/www.e-cancer.fr\/Expertises-et-publications\/Catalogue-des-publications\/Preservation-de-la-fertilite-et-cancer-Thesaurus."},{"issue":"1","key":"10.1016\/j.bulcan.2025.06.001_bib0420","doi-asserted-by":"crossref","first-page":"15661","DOI":"10.1038\/s41598-023-42583-3","article-title":"Feasibility and efficiency of delayed ovarian stimulation and metaphase II oocyte banking for fertility preservation and childbearing desire after fertility-impairing treatment","volume":"13","author":"Miquel","year":"2023","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.bulcan.2025.06.001_bib0425","doi-asserted-by":"crossref","first-page":"103891","DOI":"10.1016\/j.rbmo.2024.103891","article-title":"What reproductive follow-up for adolescent and young women after cancer? A review","volume":"49","author":"Decanter","year":"2024","journal-title":"Reprod Biomed Online"},{"issue":"8","key":"10.1016\/j.bulcan.2025.06.001_bib0430","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/annonc\/mdx184","article-title":"GnRH agonist for protection against ovarian toxicity during chemotherapy for early breast cancer: the Anglo Celtic Group OPTION trial","volume":"28","author":"Leonard","year":"2017","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.bulcan.2025.06.001_bib0435","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1056\/NEJMoa1413204","article-title":"Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy","volume":"372","author":"Moore","year":"2015","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.bulcan.2025.06.001_bib0440","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1093\/annonc\/mdv374","article-title":"Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies","volume":"26","author":"Lambertini","year":"2015","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.bulcan.2025.06.001_bib0445","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/uog.18934","article-title":"Gonadotropin-releasing hormone agonists for ovarian protection during cancer chemotherapy: systematic review and meta-analysis","volume":"51","author":"Senra","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"19","key":"10.1016\/j.bulcan.2025.06.001_bib0450","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1200\/JCO.2018.78.1914","article-title":"Fertility preservation in patients with cancer: ASCO clinical practice guideline update","volume":"36","author":"Oktay","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2025.06.001_bib0455","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.breast.2018.06.012","article-title":"Prospective study to optimize care and improve knowledge on ovarian function and\/or fertility preservation in young breast cancer patients: results of the pilot phase of the PREgnancy and FERtility (PREFER) study","volume":"41","author":"Lambertini","year":"2018","journal-title":"Breast"},{"issue":"29","key":"10.1016\/j.bulcan.2025.06.001_bib0460","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1200\/JCO.21.00535","article-title":"Pregnancy after breast cancer: a systematic review and meta-analysis","volume":"39","author":"Lambertini","year":"2021","journal-title":"J Clin Oncol"},{"issue":"18","key":"10.1016\/j.bulcan.2025.06.001_bib0465","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMoa2212856","article-title":"Interrupting endocrine therapy to attempt pregnancy after breast cancer","volume":"388","author":"Partridge","year":"2023","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.bulcan.2025.06.001_bib0470","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10549-012-2368-y","article-title":"Trastuzumab administration during pregnancy: a systematic review and meta-analysis","volume":"137","author":"Zagouri","year":"2013","journal-title":"Breast Cancer Res Treat"},{"issue":"20","key":"10.1016\/j.bulcan.2025.06.001_bib0475","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.3390\/cancers15204923","article-title":"The role of cyclin-dependent kinases (CDK) 4\/6\u00a0in the ovarian tissue and the possible effects of their exogenous inhibition","volume":"15","author":"Scavone","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.bulcan.2025.06.001_bib0480","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10549-025-07702-w","article-title":"Impact of pembrolizumab on ovarian function in young triple-negative breast cancer patients treated with chemo-immunotherapy","volume":"212","author":"Perdrix","year":"2025","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"10.1016\/j.bulcan.2025.06.001_bib0485","doi-asserted-by":"crossref","first-page":"e550","DOI":"10.1016\/S1470-2045(21)00525-8","article-title":"Immunotherapy for cancer treatment during pregnancy","volume":"22","author":"Borgers","year":"2021","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.bulcan.2025.06.001_bib0490","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10815-023-02725-y","article-title":"BRCA, infertility, and fertility preservation: a review for counseling","volume":"40","author":"Baltac\u0131","year":"2023","journal-title":"J Assist Reprod Genet"},{"issue":"3","key":"10.1016\/j.bulcan.2025.06.001_bib0495","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41416-018-0139-1","article-title":"Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1\/2\u00a0mutation carriers","volume":"119","author":"Derks-Smeets","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bulcan.2025.06.001_bib0500","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.3332\/ecancer.2022.1416","article-title":"Review of the literature on combined oral contraceptives and cancer","volume":"16","author":"Kamani","year":"2022","journal-title":"Ecancermedicalscience"},{"issue":"19","key":"10.1016\/j.bulcan.2025.06.001_bib0505","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/jnci\/djn313","article-title":"Hormone therapy and the risk of breast cancer in BRCA1\u00a0mutation carriers","volume":"100","author":"Eisen","year":"2008","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.bulcan.2025.06.001_bib0255","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4143\/crt.2023.653","article-title":"Short-term impact of hormone replacement therapy on risk of breast cancer in BRCA mutation carriers: a nationwide study in South Korea","volume":"56","author":"Kim","year":"2024","journal-title":"Cancer Res Treat"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455125002656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455125002656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T13:23:44Z","timestamp":1755869024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455125002656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":51,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0007455125002656"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2025.06.001","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer du sein chez la femme en \u00e2ge de procr\u00e9er\u00a0: probl\u00e9matiques autour du r\u00f4le des hormones","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2025.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}